Anti-TIM-3 Monoclonal Antibody Sym023 (Code C150560) |
Terms & Properties |
Preferred Name: Anti-TIM-3 Monoclonal Antibody Sym023
Definition: A recombinant, fully human monoclonal antibody against the inhibitory T-cell receptor T-cell immunoglobulin and mucin domain-containing protein 3 (TIM-3; TIM3; hepatitis A virus cellular receptor 2; HAVCR2), with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, the anti-TIM-3 monoclonal antibody Sym023 binds to TIM-3 expressed on certain T-cells, including tumor infiltrating lymphocytes (TILs). This abrogates T-cell inhibition, activates antigen-specific T-lymphocytes and enhances cytotoxic T-cell-mediated tumor cell lysis, which results in a reduction in tumor cell proliferation. TIM-3, a transmembrane protein and immune checkpoint receptor, is associated with tumor-mediated immune suppression.
Display Name: Anti-TIM-3 Monoclonal Antibody Sym023
Label: Anti-TIM-3 Monoclonal Antibody Sym023
NCI Thesaurus Code: C150560 (Search for linked caDSR metadata) (search value sets)
NCI Metathesaurus Link: CL552361 (see NCI Metathesaurus info)
Synonyms & Abbreviations: (see Synonym Details)
Anti-TIM-3 Monoclonal Antibody Sym023 |
Anti-TIM3 Monoclonal Antibody Sym023 |
Sym 023 |
SYM-023 |
Sym-023 |
Sym023 |
External Source Codes:
NCI Drug Dictionary ID | 793443 (see NCI Drug Dictionary info) |
FDA UNII Code | 9GEU9XHE20 |
PDQ Closed Trial Search ID | 793443 |
PDQ Open Trial Search ID | 793443 |
NCI META CUI | CL552361 |
Other Properties:
Name | Value (qualifiers indented underneath) | ||||
---|---|---|---|---|---|
code | C150560 | ||||
Contributing_Source | CTRP | ||||
Contributing_Source | FDA | ||||
Contributing_Source | GDC | ||||
Maps_To | Anti-TIM-3 Monoclonal Antibody Sym023 | ||||
|
|||||
Semantic_Type | Amino Acid, Peptide, or Protein | ||||
Semantic_Type | Pharmacologic Substance |
Additional Concept Data:
Defined Fully by Roles: No |
URL:https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C150560 |